Effect of carbamazepine and valproate on bone mineral density
- 31 October 2004
- journal article
- Published by Elsevier BV in Pediatric Neurology
- Vol. 31 (4), 279-282
- https://doi.org/10.1016/j.pediatrneurol.2004.03.021
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of Antiepileptic Drugs on Bone Mineral Density in Children Between Ages 6 and 2 YearsClinical Pediatrics, 1999
- Evaluation of bone mineral density in children receiving antiepileptic drugsPediatric Neurology, 1998
- Effect of carbamazepine and valproate on bone mineral densityThe Journal of Pediatrics, 1995
- Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugsJournal of Bone and Mineral Research, 1994
- Development of bone mass and bone density of the spine and femoral neck — a prospective study of 65 children and adolescentsBone and Mineral, 1993
- The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systemsThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Long-Term Anticonvulsant Therapy and Vitamin D Metabolism in Ambulatory Pubertal ChildrenNeuropediatrics, 1986
- Effect of vitamin D2and D3on bone-mineral content in carbamazepine-treated epileptic patientsActa Neurologica Scandinavica, 1983
- Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?Acta Neurologica Scandinavica, 1983
- Latent Osteomalacia in Epileptic Patients on AnticonvulsantsBMJ, 1972